鼻咽癌原发灶肿瘤体积与T分期的关系(3)
[3] Nathu RM， Mancuso AA， Zhu TC，et al.The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy[J].Head& neck，2000，22(1)：1-5.
[4] Mukherji S K，O'Brien S M，Gerstle R J，et al.The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx[J].Head & neck，2000，22(3)：282-287.
[5] Lee N， Xia P， Quivey JM， et al. Intensity2modulated radiotherapy inthe treatment of nasopharyngeal carcinoma： an update of theUCSF ex2 perience[J].Int J Radiat Oncol Biol Phys，2002，53(1)：12-22.
[6]潘建基，張瑜，林少俊，等.鼻咽癌IMRT靶区及剂量设计指引专家共识 [R]中国鼻咽癌临床分期工作委员会。2010
[7] Chen Y，Liu M Z，Liang S B，et al.Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China[J].Int
J Radiat Oncol Biol Phys，2008，71(5)：1356-1364.
[8] Gespedamwiez M K，Miller D，Groome P A，et al.The process for continuous improvement of the INM classificatian[J]. Cancer，2004，110：1-5.
[9]中国鼻咽癌临床分期工作委员会。鼻咽癌’92分期修订工作报告。[R]中华放射肿瘤学杂志，2009，18：2-6.
[10] Lee W R，Mancuso A A，Saleh E M，et al.Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone[J]？ Int J Radiat Oncol Biol Phys，1993，25(4)：683-687
[11] Shen C，Lu J，Gu Y，et al.Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated bydefinitive radiation therapy.Laryngoscope[J].2008，118：1206.
[12]陈传本， 潘建基， 陈荔莎，等.调强放疗条件下鼻咽癌原发肿瘤体积对预后的影响[J].中华放射肿瘤学杂志，2012，21(3)：205-208.
(收稿日期：2017-09-18), 百拇医药(朱鹭超 傅丽蓉 吴琼 林勤)
[4] Mukherji S K，O'Brien S M，Gerstle R J，et al.The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx[J].Head & neck，2000，22(3)：282-287.
[5] Lee N， Xia P， Quivey JM， et al. Intensity2modulated radiotherapy inthe treatment of nasopharyngeal carcinoma： an update of theUCSF ex2 perience[J].Int J Radiat Oncol Biol Phys，2002，53(1)：12-22.
[6]潘建基，張瑜，林少俊，等.鼻咽癌IMRT靶区及剂量设计指引专家共识 [R]中国鼻咽癌临床分期工作委员会。2010
[7] Chen Y，Liu M Z，Liang S B，et al.Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China[J].Int
J Radiat Oncol Biol Phys，2008，71(5)：1356-1364.
[8] Gespedamwiez M K，Miller D，Groome P A，et al.The process for continuous improvement of the INM classificatian[J]. Cancer，2004，110：1-5.
[9]中国鼻咽癌临床分期工作委员会。鼻咽癌’92分期修订工作报告。[R]中华放射肿瘤学杂志，2009，18：2-6.
[10] Lee W R，Mancuso A A，Saleh E M，et al.Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone[J]？ Int J Radiat Oncol Biol Phys，1993，25(4)：683-687
[11] Shen C，Lu J，Gu Y，et al.Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated bydefinitive radiation therapy.Laryngoscope[J].2008，118：1206.
[12]陈传本， 潘建基， 陈荔莎，等.调强放疗条件下鼻咽癌原发肿瘤体积对预后的影响[J].中华放射肿瘤学杂志，2012，21(3)：205-208.
(收稿日期：2017-09-18), 百拇医药(朱鹭超 傅丽蓉 吴琼 林勤)